These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1279 related articles for article (PubMed ID: 15003157)
41. The role of preoperative chemotherapy for Wilms' tumor: the NWTSG perspective. National Wilms' Tumor Study Group. Ritchey ML Semin Urol Oncol; 1999 Feb; 17(1):21-7. PubMed ID: 10073402 [TBL] [Abstract][Full Text] [Related]
42. Clinical and surgical experience with Wilms' tumor. Long-term results of a single institution. Zugor V; Schott GE; Lausen B; Kühn R; Labanaris AP Anticancer Res; 2010 May; 30(5):1735-9. PubMed ID: 20592371 [TBL] [Abstract][Full Text] [Related]
43. Treatment of Wilms tumor: a report from the Turkish Pediatric Oncology Group (TPOG). Akyüz C; Yalçin B; Yildiz I; Hazar V; Yörük A; Tokuç G; Akici F; Büyükpamukçu N; Kale G; Atahan L; Büyükünal C; Dervişoğlu S; Atkovar GA; Melikoğlu M; Karpuzoğlu G; Olgun N; Ayan I; Oğuz A; Yariş N; Dağdemir A; Darendeliler E; Sander S; Kuyumcuoğlu U; Ozşeker N; Corapçioğlu F; Tanyeli A; Düzovali O; Aydin GB; Büyükpamukçu M Pediatr Hematol Oncol; 2010 Apr; 27(3):161-78. PubMed ID: 20367260 [TBL] [Abstract][Full Text] [Related]
44. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour. Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718 [TBL] [Abstract][Full Text] [Related]
45. Prognostic value of p53 expression in Wilms' tumor in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734 [TBL] [Abstract][Full Text] [Related]
49. The prognostic significance of basic anthropometric data in children with advanced solid tumors. Lahorra JM; Ginn-Pease ME; King DR Nutr Cancer; 1989; 12(4):361-9. PubMed ID: 2558358 [TBL] [Abstract][Full Text] [Related]
50. [Extrarenal Wilms' tumor: diagnosis and treatment review regarding a case report]. López Cubillana P; Nortes Cano L; Martínez Barba E Arch Esp Urol; 1997 Nov; 50(9):999-1001. PubMed ID: 9527829 [TBL] [Abstract][Full Text] [Related]
51. Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5. Ehrlich PF; Ritchey ML; Hamilton TE; Haase GM; Ou S; Breslow N; Grundy P; Green D; Norkool P; Becker J; Shamberger RC J Pediatr Surg; 2005 Jan; 40(1):208-12; discussion 212-3. PubMed ID: 15868587 [TBL] [Abstract][Full Text] [Related]
52. Diastolic hypertension in Wilms' tumor survivors: a late effect of treatment? A report from the National Wilms' Tumor Study Group. Finklestein JZ; Norkool P; Green DM; Breslow N; D'Angio GJ Am J Clin Oncol; 1993 Jun; 16(3):201-5. PubMed ID: 8393271 [TBL] [Abstract][Full Text] [Related]
53. Cytopathology of uncommon malignant renal neoplasms in the pediatric age group. Radhika S; Bakshi A; Rajwanshi A; Nijhawan R; Das A; Kakkar N; Joshi K; Marwaha RK; Rao KL Diagn Cytopathol; 2005 May; 32(5):281-6. PubMed ID: 15830360 [TBL] [Abstract][Full Text] [Related]
55. Incidence and outcomes of patients with late recurrence of Wilms' tumor. Malogolowkin M; Spreafico F; Dome JS; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM; Bergeron C; de Kraker J; Graf N; Pediatr Blood Cancer; 2013 Oct; 60(10):1612-5. PubMed ID: 23737480 [TBL] [Abstract][Full Text] [Related]
56. [High risk Wilms' tumor in children. Clinico-pathological correlation based on 320 patients registered in the Polish Paediatric Solid Tumor Study Group]. Sawicz-Birkowska K; Bagłaj SM; Balcerska A; Bohosiewicz J; Godziński J; Kantorowicz S; Kołecki P; Kowalczyk J; Perek D; Chrzan R Med Wieku Rozwoj; 2000; 4(1 Suppl 2):103-9. PubMed ID: 12021469 [TBL] [Abstract][Full Text] [Related]
57. Secondary leukemia following successful treatment of Wilms' tumor. Moss TJ; Strauss LC; Das L; Feig SA Am J Pediatr Hematol Oncol; 1989; 11(2):158-61. PubMed ID: 2546463 [TBL] [Abstract][Full Text] [Related]
59. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors. Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842 [TBL] [Abstract][Full Text] [Related]